Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Mutant KRAS cancers"'
The discovery of functionally relevant KRAS effectors in lung and PDAC may yield novel molecular targets or mechanisms amenable to inhibition strategies. Here, we studied the role of PITPNC1 and its controlled network in the development and progressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1111::3936bfa696ae91fd0a8d1736162506c6
https://hdl.handle.net/10171/65498
https://hdl.handle.net/10171/65498
